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Learning points for clinicians
• Mobile digital health devices that provide remote,
patient-generated information are commercially avail-
able. This can challenge traditional health care deliv-
ery models, but can potentially reduce healthcare
expenditure and improve clinical outcomes. Previous,
difficult to establish diagnoses, such as coronary ar-
tery spasm, may be made with greater certainty using
these devices.
A 61-year-old man presented with sub-sternal chest pain at rest
associated with sweating. He had a family history for premature car-
diovascular disease, but otherwise no cardiac risk factors and an ex-
cellent exercise tolerance. The symptoms had been recurrent for 3
months, and on one occasion he presented to the emergency de-
partment where both 12-lead electrocardiogram (ECG) and troponin
were normal. He was prescribed GTN spray, and following cardi-
ology review went to have a normal exercise stress echocardiogram.
He continued to experience episodes of chest discomfort
which resolved with GTN administration, during one of these
episodes he acquired a tracing using a handheld ECG device
(AliveCor Inc., USA) attached to a smartphone. The single ECG
lead tracing demonstrated ST-segment elevation with intermit-
tent ectopy (Figure 1A) which resolved following the adminis-
tration of GTN (Figure 1B).
Due to the transient ST-segment elevation, he was admitted to
hospital and underwent urgent coronary angiography. This dem-
onstrated minor atheromatous changes which, following pressure
wire assessment using intravenous adenosine, were demonstrated
not to be physiologically significant. Given the absence of exer-
tional symptoms, normal stress echocardiogram and invasive as-
sessment, the decision was made not to proceed to angioplasty.
A diagnosis of coronary artery spasm was made and treat-
ment with vasodilators (diltiazem) and statin initiated. At 6
months clinic follow-up, the patient was asymptomatic with
excellent exercise capacity.
Discussion
Recent technological advances have resulted in a wide range of
mobile digital health (mHealth) devices that are disrupting trad-
itional health care delivery. These miniaturized diagnostic in-
struments are providing remote, patient-generated information
that can potentially reduce healthcare expenditure and improve
clinical outcomes.1
Figure 1. Single-lead ECG recordings obtained with the AliveCor device during a
period of chest pain at rest demonstrated ST-elevation and an ectopic triplet (A)
and following sublingual GTN administration normalization of the ST segments
(B)—both traces obtained with mains filter: 50 Hz; Scale: 25 mm/s, 10 mm/mV.
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Case report
AliveCor incorporates electrodes for wireless cardiac telem-
etry monitoring, and approved for use by the US Food and Drug
Administration (US-FDA) and EU Medical Device Directive (EU-
MDD) in 2013. When the user rests their fingers on the sensors,
the device detects electrical impulses (representative of Lead I
when held between the right and left hand) and converts it to
an ultrasound signal that is transmitted to the mobile device’s
microphone to produce a 30 s rhythm strip. Previous studies
have established clinical effectiveness in detecting arrhythmias,
but this is the first reported case of mHealth products identify-
ing acute myocardial ischaemia.2
In 1959, Prinzmetal et al. described ‘variant angina’ and
postulated that the condition was due to vasospasm.3 The
pathophysiology of coronary artery spasm remains unclear, but
is thought to involve endothelial dysfunction and hyper-
reactivity of coronary artery smooth muscle cells. Classically,
this presents with severe chest pain, usually at rest, with a con-
current ECG showing transient ST elevation and prompt reso-
lution with short-acting nitrates—all of which are
demonstrated the our reported case.4
Contemporary diagnosis of coronary artery spasm relies on
provocation testing with intracoronary acetylcholine during in-
vasive coronary angiography—although this remains a contro-
versial area. Many cardiologists have questioned the clinical
utility of provocation testing as the results are difficult to inter-
pret and studies have demonstrated high proportions of pa-
tients with provoked spasm during invasive testing.5 The gold
standard for diagnosis would be demonstrating transient ST-
elevation during episodes of vasospasm in a patient with unob-
structed coronary arteries. This has proven elusive due to the
unpredictable nature of symptoms and the impracticality of
prolonged rhythm monitoring.
This reported case provides a succinct demonstration how
emerging mHealth devices can provide new insights into previ-
ously difficult to establish diagnoses. These devices are provid-
ing patients with accurate diagnostic tools that have the
potential to challenge the way we practice medicine. Future
work will focus on how best to analyse these vast quantities of
data, identifying clinically useful measures and ways to inte-
grate them into our existing healthcare systems to improve pa-
tient outcomes.
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